The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage

Academic Emergency Medicine

Volumn 17, Issue 3, 2010, Pages 244-251

  Nishijima, Daniel K ^a   Dager, William E ^a   Schrot, Rudolph J ^a   Holmes, James F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Factor VII; Traumatic intracranial hemorrhage; Warfarin

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY WARD; FEMALE; GLASGOW COMA SCALE; HOSPITAL DISCHARGE; HUMAN; INJURY SCALE; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MARSHALL SCORE; MORTALITY; NEUROSURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVISED TRAUMA SCORE; SCORING SYSTEM; SURVIVAL RATE; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; EMERGENCY TREATMENT; FACTOR VIIA; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGE, TRAUMATIC; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THROMBOEMBOLISM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRAUMA CENTERS; TREATMENT OUTCOME; WARFARIN;

EID: 77951142123     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2010.00666.x     Document Type: Article

References (39)

1. Meyer J. Age: 2000, Census 2000 Brief. Washington DC: US Census Bureau, 2001. Available at: http://www.census.gov/prod/2001pubs/c2kbr01-12.pdf. Accessed Nov 17, 2009.
2. Schwab CW, Shapiro MB, Kauder DR, Geriatric trauma: patterns, care and outcome. In: Mattox KL, Feliziano DV, Moore EE (eds). Trauma. New York, NY: McGraw-Hill, 2000, pp 1099-1114
3. Fleming B. Emergency case. Head injury in patients using warfarin. Can Fam Physician. 2001; 47:727-728
4. Kennedy DM, Cipolle MD, Pasquale MD, Wasser T. Impact of preinjury warfarin use in elderly trauma patients. J Trauma. 2000; 48:451-453 (Pubitemid 30183105)
5. Ferrera PC, Bartfield JM. Outcomes of anticoagulated trauma patients. Am J Emerg Med. 1999; 17:154-156
6. Karni A, Holtzman R, Bass T, et al. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg. 2001; 67:1098-1100 (Pubitemid 33738151)
7. Lavoie A, Ratte S, Clas D, et al. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma. 2004; 56:802-807 (Pubitemid 38534091)
8. Copes WS, Champion HR, Sacco WJ, Lawnick MM, Keast SL, Bain LW. The Injury Severity Score revisited. J Trauma. 1988; 28:69-77.
9. Cohen DB, Rinker C, Wilberger JE. Traumatic brain injury in anticoagulated patients. J Trauma. 2006; 60:553-557
10. Parmar KA, Rao S, Abu-Zidan FM. Head injuries in warfarinised patients. Singapore Med J. 2006; 47:676-678
11. Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS. Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients. J Trauma. 2007; 63:525-530
12. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008; 65:785-788
13. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999; 45:1113-1118 (Pubitemid 29517515)
14. Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol. 1995; 44:438-442 (Pubitemid 26057236)
15. Yasuda CL, Morita ME, Nishimori FY, Yasuda AM, Alves HL. [Chronic subdural hematoma: study of 161 patients and the relationship with coagulation abnormalities] (Portuguese). Arq Neuropsiquiatr. 2003; 61:1011-1014
16. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997; 77:477-480 (Pubitemid 27121012)
17. Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003; 349:675-683 (Pubitemid 36980605)
18. Bosch J, Thabut D, Bendtsen F, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004; 127:1123-1130 (Pubitemid 39345881)
19. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth. 2005; 95:596-602. (Pubitemid 41600019)
20. Friederich PW, Geerdink mg, Spataro M, et al. The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. Blood Coagul Fibrinolysis. 2000; 11(Suppl 1):S129-32.
21. Lodge JP, Jonas S, Oussoultzoglou E, et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology. 2005; 102:269-275 (Pubitemid 40189073)
22. Raobaikady R, Redman J, Ball JA, Maloney G, Grounds RM. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br J Anaesth. 2005; 94:586-591 (Pubitemid 40613802)
23. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005; 59:8-15. (Pubitemid 41271632)
24. Narayan RK, Maas AI, Marshall LF, Servadei F, Skolnick BE, Tillinger MN. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery. 2008; 62:776-786
25. Stein DM, Dutton RP, Kramer ME, Handley C, Scalea TM. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma. 2008; 64:620-627 (Pubitemid 351366880)
26. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005; 352:777-785 (Pubitemid 40271172)
27. Dager WE, King JH, Regalia RC, et al. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin. Pharmacotherapy. 2006; 26:1091-1098
28. Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma. 2009; 66:63-72.
29. Baglin T. Management of warfarin (coumarin) overdose. Blood Rev. 1998; 12:91-98
30. Worster A, Bledsoe RD, Cleve P, Fernandes CM, Upadhye S, Eva K. Reassessing the methods of medical record review studies in emergency medicine research. Ann Emerg Med. 2005; 45:448-451 (Pubitemid 43181016)
31. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974; 14:187-196
32. Maas AI, Hukkelhoven CW, Marshall LF, Steyerberg EW. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery. 2005; 57:1173-1182
33. Koch GG, Landis JR, Freeman JL, Freeman DH Jr, Lehnen RC. A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics. 1977; 33:133-158
34. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med. 2002; 137:884-888
35. Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg. 2003; 98:737-740 (Pubitemid 36396775)
36. Kalina M, Tinkoff G, Gbadebo A, Veneri P, Fulda G. A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy. Am Surg. 2008; 74:858-861
37. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358:2127-2137 (Pubitemid 351679599)
38. Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg. 2008; 248:61-68
39. Stanworth SJ, Birchall J, Doree CJ, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2007; 2:CD005011. (Pubitemid 351805892)